According to the Directive 2007/47/EC (7.5) requirement, manufacturers must indicate on the labelling of the medical device or on the medical device itself the presence of any compound carcinogenic, mutagenic or toxic to reproduction in accordance with Directive 67/548/EEC(Annex I). Still nowadays, no target value exists beyond which the “phthalates” or “DEHP” label must be mentioned on medical devices.